Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00558285 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: indacaterol/glycopyrrolate
DRUG: indacaterol
DRUG: glycopyrrolate
DRUG: placebo

Sponsor

Novartis